EXEL News

Latest breaking news and updates for EXEL stock.

Track all markets on TradingView

EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm

(NASDAQ:EXEL) LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exel...

When is the expected timeline for key legal disclosures or court rulings, and what indicators should we monitor for the investigation's progress? What potential financial liabilities or settlement costs could arise from the securities‑law violations, and how might they impact the company's balance sheet? How will the ongoing fraud investigation affect EXEL's short‑term stock volatility and trading volumes?
Lawsuits
8 days ago
Read more prnewswire

EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm

(NASDAQ:EXEL) LOS ANGELES--(BUSINESS WIRE)---- $EXEL--EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with the Schall Law Firm

Could the involvement of a high‑profile law firm like Schall influence investor confidence or lead to broader regulatory scrutiny for Exelixis? What potential financial penalties or settlement costs could arise from the lawsuit and how might they compare to similar cases in the biotech sector? How will the fraud investigation affect EXEL's short‑term stock volatility and liquidity?
Lawsuits
10 days ago
Read more businesswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. - EXEL

NEW YORK, Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ: EXEL). Such investors are advised to con...

Could the outcome of the investigation impact Exelixir’s upcoming product pipeline milestones or partnership agreements? Is there a timeline for the investigation’s findings that could create price volatility? How does the market’s reaction to similar class‑action lawsuits in the biotech sector compare to this case?
Lawsuits
about 1 month ago
Read more prnewswire